# Experimental Data Archive: SARS-CoV-2 PLpro Protocol

This repository contains raw and processed experimental data supporting the following publication:

**Title**: *Protocol for Production and Characterization of SARS-CoV-2 PLpro in Escherichia coli*  
**Authors**: Anna De Falco¹²³\*, Rebecca Greene-Cramer¹²³\*, Ben A. Surina¹², Suren Zakian¹², Thomas B. Acton¹², Theresa A. Ramelot¹², and Gaetano T. Montelione¹²⁴\*\*  
¹ Center for Biotechnology and Interdisciplinary Sciences, Rensselaer Polytechnic Institute, Troy, NY, USA  
² Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY, USA  
³ Technical Contacts: [defala@rpi.edu](mailto:defala@rpi.edu), [greenr9@rpi.edu](mailto:greenr9@rpi.edu)  
⁴ Lead Contact: [monteg3@rpi.edu](mailto:monteg3@rpi.edu)  
\* These authors contributed equally  
\*\* Corresponding author  

### Preprint  
Published in bioRxiv (2025):  
**"From Plasmid to Pure Protein: Production and Characterization of SARS-CoV-2 PLpro"**  
[PMCID: PMC11952365](https://pmc.ncbi.nlm.nih.gov/articles/PMC11952365/)

---

## Repository Contents

This dataset includes representative raw and analyzed data from the fluorescence-based enzyme assays and NMR characterization of SARS-CoV-2 PLpro, as described in the above protocol.

**Files included:**

- `MM_complete.prism` — Michaelis-Menten assay data in Prism format  
- `GRL0617_inhibition.prism` — Dose-response inhibition data for GRL0617  
- `raw_data_michaelis_menten_experiment.xlsx` — Raw fluorescence measurements for kinetic analysis  
- `PLpro_NMR_spectrum.*` — NMR data file (file extension depends on instrument/export format)

---

## Experimental Overview

We describe an E. coli expression and purification protocol for SARS-CoV-2 papain-like protease (PLpro), followed by biophysical characterization using:

- **Mass spectrometry**  
- **Nuclear Magnetic Resonance (NMR)**  
- **Fluorescence-based enzyme inhibition assays**

The peptide substrate used in activity assays was **Z-Arg-Leu-Arg-Gly-Gly-AMC Acetate**, mimicking the PLpro cleavage site (RLRGG/X), and GRL0617 was tested as a known inhibitor.

---

## Software and Tools Used

- **TopSpin 4.2.0** ([Bruker](https://www.bruker.com/en/products-andsolutions/mr/nmr-software/topspin.html))  
- **POKY9** ([POKY NMR Tools](https://sites.google.com/view/pokynmr))  
- **NMRFAM SPARKY** ([NMRFAM](https://nmrfam.wisc.edu/nmrfam-sparky-distribution/))  
- **Magellan™ v7.2** ([Tecan](https://lifesciences.tecan.com/software-magellan))  
- **GraphPad Prism** ([GraphPad](https://www.graphpad.com))  
- **Microsoft Excel** ([Microsoft 365](https://www.microsoft.com/en-us/microsoft-365/excel))

---

## Citation

If you use these data or protocols, please cite the published protocol and/or preprint:

> De Falco A, Greene-Cramer R, Surina BA, Zakian S, Acton TB, Ramelot TA, Montelione GT. (2025). *From Plasmid to Pure Protein: Production and Characterization of SARS-CoV-2 PLpro.* bioRxiv. [PMC11952365](https://pmc.ncbi.nlm.nih.gov/articles/PMC11952365/)

---

## Contact

For technical questions, please contact:

- [defala@rpi.edu](mailto:defala@rpi.edu)
- [greenr9@rpi.edu](mailto:greenr9@rpi.edu)
- [monteg3@rpi.edu](mailto:monteg3@rpi.edu) (lead contact)

---

**Repository maintained by the Montelione Lab, Rensselaer Polytechnic Institute.**
